Dermatology clinical trials
Our founding specialty and deepest bench: embedded research sites inside high-volume dermatology practices, with severity-tagged patient panels and infrastructure ready for topical, oral, injectable, and device protocols, including complex and rare-disease work.
Request dermatology feasibilityWhat dermatology capabilities do the sites have?
- 1M+ active patient database across network dermatology practices, tagged by indication and severity (PASI/BSA bands, Norwood grades).
- Dedicated exam rooms for research visits, plus full waiting-room and front-desk integration.
- Mohs surgery services at several sites, supporting skin-cancer and procedure-adjacent protocols.
- Access-controlled IP room, -20 and -70 freezers, centrifuge and incubator.
- EKG, blood pressure, scales, and on-site lab area for safety and PK-light assessments.
- Experienced coordinators and an embedded medical monitor for eligibility and safety calls in hours, not queues.
Where are the sites?
What dermatology work is running now?
Active and upcoming work spans moderate-to-severe acne, plaque psoriasis, androgenetic alopecia, lichen sclerosus, and skin cancer, across Phase 2 and Phase 3. Sponsor names and study identifiers stay confidential; for specifics against your protocol, send a synopsis and get an answer in 48 business hours, built the way we describe in how we build an enrollment number.
Frequently Asked Questions (FAQs)
What dermatology indications can Stryde sites support?
Acne (adult and pediatric), plaque psoriasis, atopic dermatitis, androgenetic alopecia, lichen sclerosus, hidradenitis suppurativa, and rare dermatoses, with severity-graded patient tagging in the practice EMRs. If your indication is not listed, ask; the census updates quarterly.
Can these sites handle injectable and biologic protocols?
Yes. Sites include access-controlled IP storage, -20 and -70 freezers, centrifuge and incubator capability, and coordinators experienced with biologic administration and cold-chain handling.
How fast can a dermatology site activate?
Median network startup runs 6.5 weeks, and depending on sponsor needs and document readiness we can activate in as little as two weeks. See the performance board.
How do I get dermatology feasibility numbers?
Send a protocol synopsis to trials@stryderesearch.com. Preliminary feasibility, from real tagged patient counts, in 48 business hours.
Planning a dermatology protocol?
Preliminary feasibility from tagged patient counts in 48 business hours, or an honest answer within 4 hours on why it needs longer.